Summary
- Profile Type
- Business Offer
- POD Reference
- BOGR20250512004
- Term of Validity
- 12 May 2025 - 12 May 2026
- Company's Country
- Greece
- Type of partnership
- Commercial agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- Α Greek med-tech company specializing in producing intravenous (IV) solutions has developed niche clinical decision support systems (CDSS) and computerized physician order entry (CPOE) software designed to streamline the management of parenteral nutrition and chemotherapy. The company is willing to collaborate with international partners in the health sector under commercial agreements.
- Full Description
-
The Greek company is an innovative, healthcare provider that develops software solutions and offers specialized pharmaceutical, nutritional, and consultancy services. These services are tailored to meet the needs of healthcare industry stakeholders, including hospitals, compounding centers, and private individuals requiring outpatient treatment.
The company is a leader in producing custom parenteral nutrition solutions domestically, with an annual output of approximately 50,000 IV solutions. It also leverages its clinical and laboratory expertise to help hospitals establish efficient IV room workflows and safety protocols, offering training and consultancy services.
The medical software solutions offered by the company streamline critical healthcare workflows by automating processes for both parenteral nutrition and chemotherapy management. These solutions ensure safety, accuracy, and efficiency by integrating clinical guidelines, automating calculations, and providing patient-specific recommendations. They improve care quality, minimize errors, and enhance communication among healthcare teams. With built-in decision support, safety alerts, and real-time data tracking, they foster adherence to protocols and optimize treatment outcomes in hospitals, compounding centers, and other healthcare settings. These solutions are customizable, integrate seamlessly with existing systems, and are trusted by healthcare providers worldwide, as they improve operational efficiency, patient safety, and treatment quality.
They are used in more than 15 countries including UK, Germany, Singapore, and beyond, and their success stems from a design focused on clinical and end-user perspective, by a team that precisely comprehends its customer’s needs and varying workflows.
The company is seeking new partners under commercial agreements within the healthcare industry. The company is interested in finding additional partners primarily in Western Europe and the Nordic region, but no countries are excluded. Potential partners include hospitals, healthcare facilities, compounding centers, private individuals requiring outpatient treatment, as well as medical device manufacturers and medical device or software distributors. - Advantages and Innovations
-
The company continuously improves its performance and processes to deliver maximum value to partners and patients while ensuring cost-effective services. Committed to quality, it adheres to ISO 15224:2016, ISO 9001:2015 and ISO 13485:2016 certifications. Through innovation, the company integrates cutting-edge technologies and incorporates the latest academic findings, ensuring high-quality and impactful healthcare solutions.
The solutions offered by the company are niche, highly specialized medical software solutions, exceeding competitive offerings through innovative design and development driven by end-users, for end-users. These solutions streamline complex healthcare workflows, such as parenteral nutrition and chemotherapy management, by automating calculations, integrating clinical guidelines, and offering real-time patient data tracking. With enhanced safety features, compatibility checks, and customizable integration, these solutions are poised to drive efficiency and improve patient care across healthcare settings globally. - Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR status
- No IPR applied
Partner Sought
- Expected Role of a Partner
- The Greek company is seeking commercial partners involved in the healthcare sector to offer their medical device software solutions. They are willing to establish commercial agreements with foreign partners such as hospitals, healthcare facilities, compounding centers, private individuals requiring outpatient treatment. Expected partners could be also distributors of medical devices or software with the aim to distribute the offered software solutions into their domestic markets.
- Type and Size of Partner
- SME 50 - 249
- SME 11-49
- Big company
- Other
- Type of partnership
- Commercial agreement
Dissemination
- Technology keywords
- 06005004 - Remote diagnostics
- 01003006 - Computer Software
- 06001003 - Cytology, Cancerology, Oncology
- 01004001 - Applications for Health
- Market keywords
- 05007004 - Monitoring equipment
- 05005021 - Medical computer sciences
- 02007022 - Software services
- 05005014 - Oncology
- 02007012 - Medical/health software
- Sector Groups Involved
- Health
- Targeted countries
- All countries